Promacta receives FDA approval for first-line treatment of severe aplastic anemia (SAA) and Breakthrough Therapy designation for low platelet counts […]
Organizations worldwide trust Proofpoint to educate employees and reduce risk with advanced threat phishing simulations and security awareness training SUNNYVALE, […]